Robert Gramling, MD

A significant proportion of prostate-specific antigen (PSA) tests with abnormal results— nearly half—normalize over 1 to 4 years of follow-up without any medical or surgical intervention. This information can be used by physicians and their patients in shared decision-making about both PSA screening and in deciding how to follow up an abnormal result.

A significant proportion of prostate-specific antigen (PSA) tests with abnormal results— nearly half—normalize over 1 to 4 years of follow-up without any medical or surgical intervention. This information can be used by physicians and their patients in shared decision-making about both PSA screening and in deciding how to follow up an abnormal result.

A significant proportion of prostate-specific antigen (PSA) tests with abnormal results— nearly half—normalize over 1 to 4 years of follow-up without any medical or surgical intervention. This information can be used by physicians and their patients in shared decision-making about both PSA screening and in deciding how to follow up an abnormal result.